In:
International Journal of Cancer, Wiley, Vol. 140, No. 4 ( 2017-02-15), p. 914-921
Abstract:
What's new? Cancer cells boost clotting activity, which not only puts cancer patients at increased risk of dangerous blood clots but feeds the growth and spread of the tumors themselves. These authors wondered whether testing for D‐dimer, a stable protein fragment left behind after the body breaks up a blood clot, could provide information relevant to prognosis. They showed that D‐dimer levels correspond to tumor thickness and progression; elevated amounts of D‐dimer indicated a shorter progression‐free survival. Thus identifying which patients have excess D‐dimer could indicate a more aggressive treatment course, one which might potentially include anticoagulants.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8